Shenyang, China

Shicun Ma

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Shenyang Research Institute of Chemical Industry, Sinochem Corporation. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shicun Ma. Retrieved from https://idiyas.com/inventor/shicun-ma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Shicun Ma

Introduction: Shicun Ma, a pioneering inventor hailing from Shenyang, China, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Shicun Ma's latest patents include advancements in artificial intelligence algorithms for autonomous vehicles, smart city infrastructure, and renewable energy technologies.

Career Highlights: With a career spanning over two decades, Shicun Ma has worked tirelessly to push the boundaries of innovation. His notable achievements include the development of a revolutionary medical device for early disease detection and a patented system for optimizing industrial processes.

Collaborations: Throughout his career, Shicun Ma has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His collaborative efforts have resulted in cutting-edge solutions that have transformed various industries.

Conclusion: Shicun Ma's relentless pursuit of innovation and his passion for creating technology that makes a positive impact on society have solidified his reputation as a visionary inventor in the global tech community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…